Dopacone 200+50+200mg Tablet – Levodopa 200mg + Carbidopa 50mg + Entacapone 200m
Dopacone 200+50+200mg Tablet – Levodopa 200mg + Carbidopa 50mg + Entacapone 200m
Dopacone 200+50+200mg Tablet – Levodopa 200mg + Carbidopa 50mg + Entacapone 200m
Description
Dopacone 200+50+200mg Tablet – Maximum-Dose Triple Combination for Advanced Parkinson’s Control
Dopacone 200+50+200mg Tablet delivers the highest available single-tablet dose of Levodopa 200mg, Carbidopa 50mg, and Entacapone 200mg, specially formulated for patients with advanced Parkinson’s disease who experience significant motor fluctuations and “wearing-off” symptoms. By combining the dopamine precursor (Levodopa), a peripheral decarboxylase inhibitor (Carbidopa), and a COMT inhibitor (Entacapone), this high-strength tablet dramatically extends Levodopa’s half-life, increases “on” time by up to 1.5–2 hours per dose, reduces daily tablet burden, and provides smoother, more consistent control of tremors, rigidity, and bradykinesia throughout the day.


